>AT3G45140.1 |  LOX2 (LIPOXYGENASE 2) lipoxygenase 
MYCRESLSSLQTLNVAKSLSSLFPKQSALINPISAGRRNNLPRPNLRRRCKVTASRANIE 
QEGNTVKEPIQNIKVKGYITAQEEFLEGITWSRGLDDIADIRGRSLLVELISAKTDQRIT 
VEDYAQRVWAEAPDEKYECEFEMPEDFGPVGAIKIQNQYHRQLFLKGVELKLPGGSITFT 
CESWVAPKSVDPTKRIFFSDKSYLPSQTPEPLKKYRKEELETLQGKNREEVGEFTKFERI 
YDYDVYNDVGDPDNDPELARPVIGGLTHPYPRRCKTGRKPCETDPSSEQRYGGEFYVPRD 
EEFSTAKGTSFTGKAVLAALPSIFPQIESVLLSPQEPFPHFKAIQNLFEEGIQLPKDAGL 
LPLLPRIIKALGEAQDDILQFDAPVLINRDRFSWLRDDEFARQTLAGLNPYSIQLVEEWP 
LISKLDPAVYGDPTSLITWEIVEREVKGNMTVDEALKNKRLFVLDYHDLLLPYVNKVREL 
NNTTLYASRTLFFLSDDSTLRPVAIELTCPPNINKPQWKQVFTPGYDATSCWLWNLAKTH 
AISHDAGYHQLISHWLRTHACTEPYIIAANRQLSAMHPIYRLLHPHFRYTMEINARARQS 
LVNGGGIIETCFWPGKYALELSSAVYGKLWRFDQEGLPADLIKRGLAEEDKTAEHGVRLT 
IPDYPFANDGLILWDAIKEWVTDYVKHYYPDEELITSDEELQGWWSEVRNIGHGDKKDEP 
WWPVLKTQDDLIGVVTTIAWVTSGHHAAVNFGQYGYGGYFPNRPTTTRIRMPTEDPTDEA 
LKEFYESPEKVLLKTYPSQKQATLVMVTLDLLSTHSPDEEYIGEQQEASWANEPVINAAF 
ERFKGKLQYLEGVIDERNVNITLKNRAGAGVVKYELLKPTSEHGVTGMGVPYSISI*
>AT5G18110.1 |  NCBP (NOVEL CAP-BINDING PROTEIN) RNA binding / translation initiation factor 
MEVLDRRDDEIRDSGNMDSIKSHYVTDSVSEERRSRELKDGDHPLRYKFSIWYTRRTPGV 
RNQSYEDNIKKMVEFSTVEGFWACYCHLARSSLLPSPTDLHFFKDGIRPLWEDGANCNGG 
KWIIRFSKVVSARFWEDLLLALVGDQLDDADNICGAVLSVRFNEDIISVWNRNASDHQAV 
MGLRDSIKRHLKLPHAYVMEYKPHDASLRDNSSYRNTWLRG*
>AT5G22290.1 |  anac089 (Arabidopsis NAC domain containing protein 89) transcription factor 
MDTKAVGVSKDTAASMEASTVFPGFKFSPTDVELISYYLKRKMDGLERSVEVIPDLEIYN 
FEPWDLPDKSIVKSDSEWFFFCARGKKYPHGSQNRRATKMGYWKATGKERDVKSGSEVIG 
TKRTLVFHIGRAPKGERTDWIMHEYCVKGVSLDDAMVVCRVRRNKEYNSGTSQKAPKPNS 
SAEKHAKVQNGATSSGSPSDWDNLVDFYLAGESGEKLLAEMAESSENLQVDNDEDFFADI 
LRDEIINLDEAVMTGNTPNEVPTLESASMEIRVLPLPNMIDKQMSSLLEERPSQKKKGKD 
ATESLSSCFVGLYSIKSVNKARWDVIIGVVALIAMLFYLE*
>AT3G48590.1 |  NF-YC1 (NUCLEAR FACTOR Y SUBUNIT C1) DNA binding / transcription activator/ transcription factor 
MDTNNQQPPPSAAGIPPPPPGTTISAAGGGASYHHLLQQQQQQLQLFWTYQRQEIEQVND 
FKNHQLPLARIKKIMKADEDVRMISAEAPILFAKACELFILELTIRSWLHAEENKRRTLQ 
KNDIAAAITRTDIFDFLVDIVPRDEIKDEAAVLGGGMVVAPTASGVPYYYPPMGQPAGPG 
GMMIGRPAMDPNGVYVQPPSQAWQSVWQTSTGTGDDVSYGSGGSSGQGNLDGQG*
>AT1G36340.1 |  UBC31 (ubiquitin-conjugating enzyme 31) small conjugating protein ligase/ ubiquitin-protein ligase 
MFKKMDKKAAQRIAMEYRAMISKESLFSIGQNSNNIYEWTAVIRGPDGTPYEGGMFNLSI 
KFPTDYPFKPPKFTFKTPIYHPNINDEGSICMNILKDKWTPALMVEKVLLSILLLLEKPN 
PDDPLVPEIGQLFKNNRFQFDQRAREFTARHANN*
>AT5G35620.2 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLV*
>AT5G35620.2 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLV*
>AT5G35620.1 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLMGIGKKWKEILDVT 
DKITFNNHDDSRRSRFTV*
>AT5G35620.1 |  LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor 
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE 
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL 
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLMGIGKKWKEILDVT 
DKITFNNHDDSRRSRFTV*
>AT5G10260.1 |  AtRABH1e (Arabidopsis Rab GTPase homolog H1e) GTP binding 
MASVSPLAKYKLVFLGDQSVGKTSIITRFMYDKFDTTYQATIGIDFLSKTMYLEDRTVRL 
QLWDTAGQERFRSLIPSYIRDSSVAVIVYDVANRQSFLNTSKWIEDVRTERGSDVIIVLV 
GNKTDLVDKRQVSIEEGDNKARDYGVIFIETSAKAGFNIKPLFRKIAAALPGMETLSSTK 
QEDMVDVNLKTSSNSAQGEQQRGGCAC*
>AT4G34370.1 |  ARI1 (ARIADNE) protein binding / zinc ion binding 
MDDYFSAEEEACYYSSDQDSLDGIDNEESELQPLSSKRSNTQVITQESLLAAQREDLLRV 
MELLSIKEHHARTLLIHYQWDVEKLFAVFVEKGKDSLFSGAGVTVFDYQYGNSSFPQSSQ 
MSCDVCMEDLPGDHMTRMDCGHCFCNNCWTEHFTVQINEGQSKRIRCMAHQCNAICDEDI 
VRSLVSKKRPDLAAKFDRYLLESYIEDNRMVKWCPSTPHCGNAIRAEDDKLCEVECSCGL 
QFCFSCLCQAHSPCSCLMWELWRKKCRDESETINWITVHTKLCPKCYKPVEKNGGCNLVR 
CICGQCFCWLCGGATGSDHTYRSIAGHSCGRYQDDKEKQMERAKRDLNRYTHYHHRYKAH 
TDSSKLEDKLRDTIHEKVSKSEKRELKLKDFSWVTNGLDRLFRSRRVLSYSYAFAYYMFG 
EEMFKDEMTPEEREIKKNLFEDQQQQLESNVEKLSQFLEEPFDEFSNDKVMAIRIQIINL 
SVAVDTLCKKMYECIENDLLGSLQLGIHNISPYRSKGIEQAAQFYASWNSKDADKFQPLD 
SGTSGVTSRPEQASGSRSSEDTICSSSQKRPKKEGSFLNNKVTLLDLNLPADFVDQN*
>AT1G29550.1 |  eukaryotic translation initiation factor 4E putative / eIF-4E putative / eIF4E putative / mRNA cap-binding protein putative 
MVVTDSPVSGIMADQNIDPNTTTSPSPKEKHVSAIKAISGDEKAPSKEKKNYASKKSTTV 
IQKSHCFQNSWTFWFDNPSSKSNQVIWGSSLRSLYTFGTIEEFWSLYNNIHPPTKWVSGA 
DLYCFKDKIEPKWEDPICANGGKWSMMFPKATLECNWLNTLLALVGEQFDQGDEICGAVL 
NFRARGDRISLWTKNAANEEAQLSIGKQWKELLGYNETIGFIVHEDAKTLDRDAKRRYTV 
*